Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
BFLY 
Butterfly Network Inc (BFLY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/31/2025: BFLY (2-star) is a SELL. SELL since 2 days. Simulated Profits (10.27%). Updated daily EoD!
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3.17
1 Year Target Price $3.17
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -50.13% | Avg. Invested days 25 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/31/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 679.50M USD | Price to earnings Ratio - | 1Y Target Price 3.17 |
Price to earnings Ratio - | 1Y Target Price 3.17 | ||
Volume (30-day avg) 4 | Beta 2.6 | 52 Weeks Range 1.32 - 4.98 | Updated Date 11/1/2025 |
52 Weeks Range 1.32 - 4.98 | Updated Date 11/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.28 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-30 | When - | Estimate -0.0433 | Actual -0.04 |
Profitability
Profit Margin -71.78% | Operating Margin (TTM) -60.36% |
Management Effectiveness
Return on Assets (TTM) -13.72% | Return on Equity (TTM) -29.42% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 366928535 | Price to Sales(TTM) 7.76 |
Enterprise Value 366928535 | Price to Sales(TTM) 7.76 | ||
Enterprise Value to Revenue 4.19 | Enterprise Value to EBITDA -9.57 | Shares Outstanding 225314153 | Shares Floating 192637317 |
Shares Outstanding 225314153 | Shares Floating 192637317 | ||
Percent Insiders 14.3 | Percent Institutions 47.65 |
Upturn AI SWOT
Butterfly Network Inc
Company Overview
History and Background
Butterfly Network was founded in 2011 by Jonathan Rothberg. It aimed to democratize medical imaging using a single silicon chip. Significant milestones include FDA approval for its Butterfly iQ device and its public listing through a SPAC merger with Longview Acquisition Corp in 2021.
Core Business Areas
- Point-of-Care Ultrasound: Develops and commercializes the Butterfly iQ+, a handheld, whole-body ultrasound device connected to a mobile app.
- Digital Health Platform: Provides a software platform including image management, reporting, and educational resources for users.
- Enterprise Solutions: Offers solutions for hospitals and healthcare systems to manage ultrasound workflows and improve patient care.
Leadership and Structure
Dr. Joseph DeVivo is the CEO. The company has a typical corporate structure with departments for engineering, sales, marketing, finance, and operations.
Top Products and Market Share
Key Offerings
- Butterfly iQ+: A handheld, whole-body ultrasound device that connects to a mobile app. Market share is growing but still relatively small compared to traditional ultrasound vendors. Competitors include GE Healthcare (GE), Philips (PHG), and Siemens Healthineers (SIEGY). Estimated revenue from this product comprises most of the total revenue for Butterfly.
- Butterfly Cloud: A secure cloud platform for storing, sharing, and managing ultrasound images and data. Revenue is growing as more users adopt the iQ+ device and utilize the cloud services. Competitors include GE Health Cloud and Philips HealthSuite.
- Butterfly Education: A medical education and collaboration platform, offering learning modules, case reviews, and community engagement tools. Revenue is generated through subscriptions. No other competitor provides such a focused offering
Market Dynamics
Industry Overview
The medical imaging market is large and growing, driven by factors such as an aging population, increasing prevalence of chronic diseases, and technological advancements. Point-of-care ultrasound (POCUS) is a rapidly expanding segment within this market.
Positioning
Butterfly Network is positioned as an innovator in the POCUS market, offering a low-cost, portable, and user-friendly ultrasound solution. Its competitive advantage lies in its silicon chip technology, which enables it to offer a more affordable device compared to traditional ultrasound systems.
Total Addressable Market (TAM)
The global ultrasound market is estimated to be in the tens of billions USD annually. The POCUS market is projected to grow significantly. Butterfly Network is positioned to capture a portion of this growing market with its disruptive technology. TAM estimate is between $8 billion and $12 billion annually.
Upturn SWOT Analysis
Strengths
- Disruptive technology with silicon chip ultrasound
- Low-cost compared to traditional ultrasound systems
- Portable and user-friendly device
- Strong brand recognition in the POCUS space
- Integrated cloud platform for image management and collaboration
Weaknesses
- Limited clinical evidence compared to established ultrasound vendors
- Reliance on single product line (Butterfly iQ+)
- Slower image processing speed compared to traditional Ultrasound devices
- Higher upfront costs compared to a conventional stethoscope or other exam tool
Opportunities
- Expanding applications of POCUS in various medical specialties
- Increasing adoption of telemedicine and remote patient monitoring
- Growth in emerging markets with limited access to medical imaging
- Partnerships with healthcare providers and technology companies
- Development of new AI-powered features and applications
Threats
- Competition from established ultrasound vendors with greater resources
- Technological advancements that could render its technology obsolete
- Regulatory hurdles and reimbursement challenges
- Economic downturns that could impact healthcare spending
- Data security and privacy concerns
Competitors and Market Share
Key Competitors
- GE (GE)
- Philips (PHG)
- Siemens Healthineers (SIEGY)
Competitive Landscape
Butterfly Network faces significant competition from established players with greater resources and brand recognition. However, its disruptive technology and low-cost solution give it a competitive edge in the POCUS market. The long-term success relies on BFLY being able to scale up quickly.
Growth Trajectory and Initiatives
Historical Growth: Revenue growth has been positive but not yet profitable.
Future Projections: Analyst estimates project continued revenue growth as the company expands its market reach and introduces new products and features.
Recent Initiatives: Recent initiatives include expanding its sales force, developing new AI-powered applications, and entering into partnerships with healthcare providers.
Summary
Butterfly Network is a disruptive company in the point-of-care ultrasound market with innovative technology. While revenue is growing and gross profit margin is improving, it's operating at a loss. Key strengths include its low-cost device and integrated cloud platform; key weaknesses include its reliance on a single product. Butterfly Network must scale up to secure its long term success, and it will need to be wary of large medical companies, that can develop their own POCUS device.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Butterfly Network Inc
Exchange NYSE | Headquaters Burlington, MA, United States | ||
IPO Launch date 2020-07-13 | CEO, President & Chairman of the Board Mr. Joseph M. DeVivo | ||
Sector Healthcare | Industry Medical Devices | Full time employees 190 | Website https://www.butterflynetwork.com |
Full time employees 190 | Website https://www.butterflynetwork.com | ||
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly iQ+ Bladder, a specialty product for the bladder scanning market; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. It also provides Butterfly system, which includes probes, related accessories, and software subscriptions to healthcare systems, physicians, and healthcare providers. In addition, the company offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments; and ScanLab, an education-only app that provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. It sells its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.